Dallas Innovates is owned by the Dallas Regional Chamber. Editorial operations are led independently by Lawley Head Media.
[email protected]© Copyright 2026 | All rights reserved.
Fort Worth-based Nacuity Pharmaceuticals won a patent this week for a method of treating retinitis pigmentosa with an oral antioxidant drug. This illustration shows pigment deposits in the retina, a sign of the genetic eye disease. [Illustration: AdobeStock]